Literature DB >> 19440019

The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.

Kang Su Cho1, Joo Wan Seo, Sung Jin Park, Young Hoon Lee, Young Deuk Choi, Nam Hoon Cho, Seung Choul Yang, Sung Joon Hong.   

Abstract

PURPOSE: We evaluated the incidence and risk factors for urethral recurrence following radical cystectomy and urinary diversion in transitional cell carcinoma. PATIENTS AND METHODS: A retrospective review was performed of the 412 consecutive patients who underwent radical cystectomy and urinary diversion for transitional cell carcinoma of the bladder between 1986 and 2004. A total of 294 patients were enrolled in this study. We investigated the impact of various clinical and pathological features on urethral recurrence by univariate and multivariate analysis.
RESULTS: Urethral recurrence developed in 13 patients (4.4%) and the 5-year urethral recurrence-free probability was 94.9%. On univariate analysis, positive urethral margin, prostatic stromal invasion, and prostatic urethral involvement had a significant influence on urethral recurrence (p < 0.05). The other clinical and pathological features were not significantly associated with urethral recurrence (p > 0.05). A multivariate Cox proportional hazard model revealed that a positive urethral margin (hazards ratio (HR) = 18.33, p < 0.001), prostatic urethral involvement (HR = 7.95, p < 0.001), and prostatic stromal invasion (HR = 5.80, p = 0.018) were independent risk factors for urethral recurrence.
CONCLUSION: A positive urethral margin is considered an absolute indication for prophylactic urethrectomy. In addition, more careful patient selection is necessary for orthotopic urinary diversion in patients with prostatic urethral involvement and prostatic stromal invasion. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19440019     DOI: 10.1159/000209363

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

1.  Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?

Authors:  Stefan Tritschler; Clarissa Mosler; Julia Straub; Alexander Buchner; Alexander Karl; Anno Graser; Christian Stief; Derya Tilki
Journal:  World J Urol       Date:  2011-12-25       Impact factor: 4.226

Review 2.  [Follow-up of bladder cancer : The right examinations at the right time].

Authors:  P Olbert; P J Goebell; A Hegele
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

3.  Evaluation of gel spun silk-based biomaterials in a murine model of bladder augmentation.

Authors:  Joshua R Mauney; Glenn M Cannon; Michael L Lovett; Edward M Gong; Dolores Di Vizio; Pablo Gomez; David L Kaplan; Rosalyn M Adam; Carlos R Estrada
Journal:  Biomaterials       Date:  2010-10-15       Impact factor: 12.479

Review 4.  Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.

Authors:  Georgios Gakis; Peter C Black; Bernard H Bochner; Stephen A Boorjian; Arnulf Stenzl; George N Thalmann; Wassim Kassouf
Journal:  Eur Urol       Date:  2016-10-06       Impact factor: 20.096

5.  Development and Validation of a Model for Predicting Urethral Recurrence in Male Patients with Muscular Invasive Bladder Cancer After Radical Cystectomy Combined with Urinary Diversion.

Authors:  Zeqi Liu; Xuanyu Zhang; Bin Wu; Yueyang Zhao; Song Bai
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

Review 6.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

Review 7.  [Preneoplastic lesions and precursors of urothelial cancer].

Authors:  R Knüchel-Clarke; N T Gaisa
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

8.  Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.

Authors:  Xinyuan Li; Wuwan Wang; Gongmin Zhu; Weiyang He; Xin Gou
Journal:  Oncotarget       Date:  2017-12-19

9.  Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10-year, single center experience.

Authors:  Nozomi Hayakawa; Nobuyuki Kikuno; Hiroki Ishihara; Osamu Ryoji; Kazunari Tanabe
Journal:  Springerplus       Date:  2015-08-08

10.  Hybrid procedure using perineal and abdominal approaches for radical prostatocystectomy: initial experience with 16 select cases.

Authors:  Yozo Mitsui; Hiroaki Yasumoto; Haruki Anjiki; Chiaki Koike; Naoko Arichi; Takeo Hiraoka; Masahiro Sumura; Satoshi Honda; Mikio Igawa; Hiroaki Shiina
Journal:  Springerplus       Date:  2013-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.